Health tech, medtech, biotech, pharma and diagnostics companies each sell to different buyers, so we build your marketing around the people who sign off on yours.
A senior-led B2B healthcare marketing agency on transparent hourly rates and only a 30-day cancellation notice.
A working product is roughly 30% of the job (Health Tech Report). The rest is proving it to buyers who read methods sections before pricing pages.
A hospital value analysis committee runs a dozen to two dozen people across clinical, IT, finance and supply chain, and no two of them share a boss.
CIOs and CMIOs are on LinkedIn; many practicing clinicians stay off it deliberately. Reaching cardiologists takes associations and events, not a bigger retargeting budget.
Every healthcare vertical is a small market; in the Netherlands, every doctor trained at one of six universities. An overstated claim follows you to the next committee.
If your buyer is a patient or a private practice, we're the wrong agency. Our clients sell to healthcare organizations.
Every claim ships with a substantiation file. Outcome write-ups carry their method, security documentation answers the CISO before the ask, and each piece is built for a committee member to forward with their name on it.
Each healthcare segment has a buyer universe you can list, so campaigns run account-based by default: LinkedIn for the technical committee, paid search for active evaluations, and reporting on named accounts reached rather than clicks collected.
The clinicians who avoid LinkedIn sit in specialty associations and conference halls. We plan HIMSS, MEDICA and the society calendar as campaigns with target lists and follow-up nurture, not booths with a lead scanner.
Tracking pixels on health pages have produced more than $100 million in settlements since 2023, so we audit tags and consent before launch, then stage your CRM to committee milestones and report pipeline by account.
One product, written three ways: clinical outcome for the committee's physicians, integration and security for IT, total cost for finance. Each version is tested on people who hold that seat before campaigns spend anything.
In a market where one overstated claim follows you, the evidence file is the growth strategy.
Each figure comes from the client's published case study, linked from its card.
“In six to seven months we went from no campaigns to 165 engaged target contacts and 27 leads ready for sales. For a company at our stage, that is the reach we needed.”
We don’t run the same plan for every healthcare company. Your Head of Growth builds yours around your segment, your buying committee, and the evidence your buyers expect. The cards below show one example for a health tech company selling to hospitals.
We meet your leadership, sales and regulatory or quality leads, get access to the website, CRM and analytics, and agree to report on pipeline by account and by committee stage.
We interview your sales team and two or three customers, map the buying committee in your main segment, and check the CRM, tracking tags and consent setup before anything launches.
Workshops with your leadership and your clinical, regulatory and sales leads. The plan describes your product three ways, for the physicians, for IT and for finance, and names the accounts and channels to start with.
We fix tracking and consent where it falls short, connect the demo form to your CRM, and rewrite the product pages hospital visitors leave without asking for anything.
Outcome write-ups, security documentation and product pages go live, each backed by a substantiation file, so a committee member can forward them with confidence.
LinkedIn reaches the committee inside your named accounts and paid search catches the evaluations already under way, with results reported per account reached.
We choose the congresses and specialty associations your clinicians attend, HIMSS or MEDICA for example, and run each one as a campaign with a target list and follow-up.
Your CRM stages follow the committee, from the first clinical contact to IT review and procurement sign-off, so sales can see where every account stands.
Your leadership gets one report: accounts reached, committee members engaged, and pipeline created and advanced by stage. Hospital purchases often take eight to 18 months, so the report shows movement long before contracts close.
Buyer: CIOs, CMIOs, clinical operations. Regulation: HIPAA, GDPR, interoperability. Motion: committee software buying, eight to 18 months. Client: Coforix.
Buyer: scientists, R&D leads, investors. Regulation: trial rules and IP sensitivity. Motion: technical and investor-driven, six to 18 months. Client: Cradle.
Buyer: procurement, clinical evaluators, biomedical engineers. Regulation: FDA, CE, MDR. Motion: capital-equipment cycles and distributor networks.
Interviews with operators who sold into hospitals and pharma, plus three rounds of desk research, written for the companies doing the selling.
Amsterdam and New York. One team across EU MDR and GDPR markets and US FDA and HIPAA markets.
.svg)
.avif)